25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
10.04.2012
- Amgen said it will buy privately held KAI Pharmaceuticals for $315 million to gain access to an experimental treatment for a common complication suffered by chronic kidney disease...
03.04.2012
- Amgen and British drugmaker AstraZeneca announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline...
24.01.2012
- European regulators took another step towards opening the market for copies of biotech drugs on by releasing a draft guideline on how companies should test biosimilar medicines...
01.08.2011
- Biotechnology firm Amgen has reported a 3% decline in its second-quarter profit as higher operating expenses offset increased product sales. However, adjusted earnings per share...
19.07.2011
- Amgen announced that the United States District Court in Pennsylvania has entered final judgment and a permanent injunction against Teva Pharmaceutical Industries and Teva...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
29.03.2011
- The worldwide market for copies of biotech medicines will grow to $3.7 billion by 2015, from just $243 million in 2010, as a raft of branded drugs lose patent cover, according to...
